Skip to Content

Ombitasvir

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AX67

CAS registry number (Chemical Abstracts Service)

1258226-87-7

Chemical Formula

C50-H67-N7-O8

Molecular Weight

894

Therapeutic Categories

Antiviral agent: Treatment of hepatitis C

Inhibitor of the NS5A protease

Chemical Name

Dimethyl N,N'-{[(2S,5S)-1(4-tert-butylphenyl)pyrrolidine-2,5-diyl]-bis-{[(4,1-phenyleneazanediyl)carbonyl][(2S)-pyrrolidine-2,1-diyl)}[(2S)-3-methyl-1-oxobutane-1,2-diyl])}biscarbamate (WHO)

Foreign Names

  • Ombitasvirum (Latin)
  • Ombitasvir (German)
  • Ombitasvir (French)
  • Ombitasvir (Spanish)

Generic Names

  • Ombitasvir (OS: USAN)
  • ABT-267 (IS)
  • UNII-2302768XJ8 (IS)

Brand Names

  • Technivie (Ombitasvir and Paritaprevir, + Ritonavir)
    AbbVie, United States
  • Viekira Pak (Ombitasvir and Dasabuvir, + Paritaprevir, + Ritonavir)
    AbbVie, United States
  • Viekirax (Ombitasvir and Paritaprevir, + Ritonavir)
    AbbVie, Switzerland; AbbVie, Germany; AbbVie, France; AbbVie, United Kingdom; AbbVie, Ireland; AbbVie, Slovenia; AbbVie Polska, Poland; AbbVie S.r.L., Slovakia

International Drug Name Search

Glossary

TermDefinition
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide